BOSTON SCIENTIFIC CORP (BSX)
Data as of , from SEC Form 4 filings.
See up to 3 months of BSX. The 7-day demo opens the 1M and 3M ranges and puts BSX on your watchlist.
Start 7-day demoLatest BSX insider trades
- Susan E. Morano - DirectorOpen-market purchase$100K
David C. Habiger - DirectorOpen-market purchase$100K
About BOSTON SCIENTIFIC CORP (BSX)
Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
- MARLBOROUGH, MA
- 59,000
- 1992
- XNYS
https://www.bostonscientific.comSEC filings for BSX on EDGAR
BSX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 6 | 196,562 | $9.49M |
| Option exercise | 2 | 2,342 | |
| Tax withholding / forfeiture | 1 | 567 | |
BSX insider transactions (Form 4)
4976 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| David S. Wichmann - Director | Grant or award | Common Stock | 2,081 | $0.00 | - | |
 Yoshiaki Fujimori - Director | Grant or award | Common Stock | 2,081 | $0.00 | - | |
 Edward J. Ludwig - Director | Grant or award | Common Stock | 2,081 | $0.00 | - | |
| Wendy Carruthers - Officer | Option exercise | Common Stock | 3,066 | $17.26 | $53K | |
| Wendy Carruthers - Officer | Option exercise | Common Stock | 1,197 | $24.55 | $29K | |
| Wendy Carruthers - Officer | Open-market sale | Common Stock | 6,983 | $90.78 | $634K | |
| Wendy Carruthers - Officer | Option exercise | Stock Option (Right to Buy) | 3,066 | $0.00 | - | |
| Wendy Carruthers - Officer | Option exercise | Stock Option (Right to Buy) | 1,197 | $0.00 | - | |
| Emily Woodworth - Officer | Open-market sale | Common Stock | 1,336 | $90.65 | $121K | |
| Michael F. Mahoney - Officer | Gift | Common Stock | 7,800 | $0.00 | - | |
 Joseph Michael Fitzgerald - Officer | Gift | Common Stock | 1,113 | $0.00 | - | |
| Joseph Michael Fitzgerald - Officer | Gift | Common Stock | 11,236 | $0.00 | - | |
| Arthur C. Butcher - Officer | Option exercise | Common Stock | 3,177 | $22.71 | $72K | |
| Arthur C. Butcher - Officer | Option exercise | Common Stock | 1,009 | $17.26 | $17K | |
| Arthur C. Butcher - Officer | Open-market sale | Common Stock | 14,010 | $89.27 | $1.25M | |
| Arthur C. Butcher - Officer | Option exercise | Stock Option (Right to Buy) | 1,009 | $0.00 | - | |
| Arthur C. Butcher - Officer | Option exercise | Stock Option (Right to Buy) | 3,177 | $0.00 | - | |
| Edward J. Ludwig - Director | Open-market sale | Common Stock | 4,877 | $91.63 | $447K | |
| John Bradley Sorenson - Officer | Gift | Common Stock | 2,610 | $0.00 | - | |
| John Bradley Sorenson - Officer | Option exercise | Common Stock | 17,362 | $24.55 | $426K | |
| John Bradley Sorenson - Officer | Open-market sale | Common Stock | 30,580 | $87.66 | $2.68M | |
| John Bradley Sorenson - Officer | Option exercise | Stock Option (Right to Buy) | 17,362 | $0.00 | - | |
| Michael F. Mahoney - Officer | Option exercise | Common Stock | 56,211 | $17.26 | $970K | |
| Michael F. Mahoney - Officer | Option exercise | Common Stock | 55,676 | $16.31 | $908K | |
| Michael F. Mahoney - Officer | Open-market sale | Common Stock | 2,596 | $85.17 | $221K | |
| Michael F. Mahoney - Officer | Open-market sale | Common Stock | 160,182 | $84.74 | $13.57M | |
| Michael F. Mahoney - Officer | Option exercise | Stock Option (Right to Buy) | 56,211 | $0.00 | - | |
| Michael F. Mahoney - Officer | Option exercise | Stock Option (Right to Buy) | 55,676 | $0.00 | - | |
| Wendy Carruthers - Officer | Option exercise | Common Stock | 3,066 | $17.26 | $53K | |
| Wendy Carruthers - Officer | Option exercise | Common Stock | 1,197 | $24.55 | $29K | |
| Wendy Carruthers - Officer | Open-market sale | Common Stock | 6,983 | $84.33 | $589K | |
| Wendy Carruthers - Officer | Option exercise | Stock Option (Right to Buy) | 3,066 | $0.00 | - | |
| Wendy Carruthers - Officer | Option exercise | Stock Option (Right to Buy) | 1,197 | $0.00 | - | |
| Michael F. Mahoney - Officer | Option exercise | Common Stock | 56,211 | $17.26 | $970K | |
| Michael F. Mahoney - Officer | Option exercise | Common Stock | 55,675 | $16.31 | $908K | |
| Michael F. Mahoney - Officer | Open-market sale | Common Stock | 80,692 | $84.31 | $6.80M | |
| Michael F. Mahoney - Officer | Open-market sale | Common Stock | 82,085 | $84.94 | $6.97M | |
| Michael F. Mahoney - Officer | Option exercise | Stock Option (Right to Buy) | 56,211 | $0.00 | - | |
| Michael F. Mahoney - Officer | Option exercise | Stock Option (Right to Buy) | 55,675 | $0.00 | - | |
| Joseph Michael Fitzgerald - Officer | Option exercise | Common Stock | 59,021 | $17.26 | $1.02M | |
| Joseph Michael Fitzgerald - Officer | Option exercise | Common Stock | 57,618 | $24.98 | $1.44M | |
| Joseph Michael Fitzgerald - Officer | Open-market sale | Common Stock | 132,527 | $85.00 | $11.26M | |
| Joseph Michael Fitzgerald - Officer | Option exercise | Stock Option (Right to Buy) | 59,021 | $0.00 | - | |
| Joseph Michael Fitzgerald - Officer | Option exercise | Stock Option (Right to Buy) | 57,618 | $0.00 | - | |
| Wendy Carruthers - Officer | Option exercise | Common Stock | 3,066 | $17.26 | $53K | |
| Wendy Carruthers - Officer | Option exercise | Common Stock | 1,197 | $24.55 | $29K | |
| Wendy Carruthers - Officer | Open-market sale | Common Stock | 6,983 | $83.86 | $586K | |
| Wendy Carruthers - Officer | Option exercise | Stock Option (Right to Buy) | 3,066 | $0.00 | - | |
| Wendy Carruthers - Officer | Option exercise | Stock Option (Right to Buy) | 1,197 | $0.00 | - |
Stock trades in BSX disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
 Kevin HernRepublican, OK-01 | Sale |
BSX insider trading FAQ
What is the latest insider trade for BSX?
BOSTON SCIENTIFIC CORP (BSX) had 9 insider filings in the last 90 days, with the most recent on 2026-09-03. The full record for BSX runs to 76 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying BSX stock?
6 insider purchases of BSX were filed in the last 90 days, totaling $9.49M.
How many insiders are selling BSX stock?
No insider sales of BSX were filed in the last 90 days. 31 sales are on record for this company.
Where can I see BSX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects BSX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Padraig Andrew O'Connor view on EDGAR
- - Susan E. Morano view on EDGAR
- - Emily Woodworth view on EDGAR
- - Jonathan Monson view on EDGAR
- - David C. Habiger view on EDGAR
- - David C. Habiger view on EDGAR
- - Michael F. Mahoney view on EDGAR
- - Edward J. Ludwig view on EDGAR
- - Joseph Michael Fitzgerald view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where BSX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow BSX with a 7-day demo
- BSX on your watchlist
- Every BSX Form 4 filing on record
- Up to 3 months of BSX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
